By Dr. Youngran ParkA new target for the treatment of endometriosis?
By Dr. Youngran Park
Endometriosis affects around 10% of women in reproductive age, estimating more than 176 million women worldwide. Inflammation in the pelvic cavity is very common in endometriosis patients. Therefore, there are high concentrations of cytokines and immune cells in the peritoneal…
Key Points Lay Summary
Novel inhibitors of estrogen biosynthesis
By Dr. Youngran Park
Endometriosis is a chronic benign disease which is estrogen-dependent. Estradiol creates a positive feedback loop with the synthesis of pro-inflammatory mediators, which sustains further disease establishment and causes the pain symptoms. However, hormone therapies do not cure definitively endometriosis, because…
Key Points Lay Summary